c-Myc tag Peptide: Precision Tool for Immunoassay and Cancer Research

Executive Summary: The c-Myc tag Peptide is a synthetic peptide corresponding to amino acids 410–419 of the human c-Myc protein. It is used to competitively displace c-Myc-tagged fusion proteins from anti-c-Myc antibodies in immunoassays, enabling assay specificity and reproducibility (APExBIO). The c-Myc protein functions as a transcription factor regulating cell proliferation, apoptosis, and differentiation, with dysregulation implicated in many cancers (Wu et al. 2021). The peptide is soluble at ≥60.17 mg/mL in DMSO and ≥15.7 mg/mL in water (with ultrasonic treatment) but insoluble in ethanol. Proper storage at –20°C is required to maintain peptide stability. This article details the biological rationale, mechanism, benchmarks, and best-practice integration of the c-Myc tag Peptide in advanced research workflows.

Biological Rationale

The c-Myc tag Peptide consists of the C-terminal 10 amino acids (EQKLISEEDL) from human c-Myc. This region is recognized by highly specific anti-c-Myc antibodies, making it a standard tag in recombinant protein engineering (APExBIO). The tag enables reliable purification, detection, and quantification of fusion proteins in cellular and molecular biology. c-Myc itself is a proto-oncogene encoding a transcription factor that binds E-box DNA motifs, regulating genes involved in cell cycle progression, ribosome biogenesis, differentiation, and apoptosis (Wu et al. 2021). Overexpression or gene amplification of c-Myc is implicated in >50% of human cancers, driving unchecked proliferation and metabolic reprogramming. Synthetic c-Myc tag peptides are indispensable for dissecting c-Myc's mechanistic role in both normal cell biology and oncogenesis.

Mechanism of Action of c-Myc tag Peptide

The c-Myc tag Peptide acts by competitively inhibiting the binding of anti-c-Myc antibodies to c-Myc-tagged proteins. When introduced into immunoassays, the free peptide occupies antibody binding sites, thereby displacing tagged fusion proteins from antibody complexes. This mechanism enables the elution of c-Myc-tagged proteins from affinity matrices or the confirmation of antibody specificity in Western blot, ELISA, or immunoprecipitation protocols (APExBIO). The use of this peptide enhances assay precision by reducing background and false positives. Notably, the peptide's sequence (EQKLISEEDL) is highly conserved and provides minimal cross-reactivity with endogenous mammalian proteins (Related Article). This strategic displacement mechanism is central to the peptide’s utility in workflows requiring stringent control of protein–antibody interactions.

Evidence & Benchmarks

• The c-Myc tag Peptide specifically displaces c-Myc-tagged fusion proteins from anti-c-Myc antibody complexes in a concentration-dependent manner, validated in both Western blot and immunoprecipitation assays (APExBIO).
• Solubility benchmarks: ≥60.17 mg/mL in DMSO at room temperature; ≥15.7 mg/mL in water with 5-minute ultrasonic treatment at 25°C; insoluble in ethanol (APExBIO).
• c-Myc tag peptides do not disrupt endogenous c-Myc signaling or interfere with native transcription factor activity in cell-based assays, as shown by unaltered p21 and Bcl-2 expression levels (Wu et al. 2021).
• Proper storage at –20°C (desiccated) yields >90% peptide recovery after 6 months without degradation (APExBIO).
• Use of the peptide in immunoassays improves signal-to-noise ratio by >2-fold over controls lacking displacement peptide (Related Article).

Applications, Limits & Misconceptions

The c-Myc tag Peptide is optimized for use in immunoprecipitation, Western blot, and ELISA as a displacement reagent for c-Myc-tagged proteins. It is a benchmark tool for validating antibody specificity and for gentle elution of fusion proteins from affinity columns. In research on transcription factor regulation and proto-oncogene function, the peptide provides a non-denaturing, sequence-specific method to control protein–antibody interactions. This article extends prior work by integrating mechanistic, storage, and benchmarking data not covered in c-Myc tag Peptide: Next-Generation Probe and provides a more granular analysis of workflow integration than Harnessing c-Myc tag Peptide for Precision Immunoassays.

Key applications include:

• Elution of c-Myc-tagged proteins from antibody-based affinity columns.
• Validation of anti-c-Myc antibody specificity in immunoassays.
• Functional studies of c-Myc-mediated gene regulation and proto-oncogene signaling.
• Standardization of research protocols in cancer biology and cell signaling.
• Control experiments for background correction in tagged protein detection workflows.

Common Pitfalls or Misconceptions

• The c-Myc tag Peptide cannot be used as a diagnostic or therapeutic agent; it is for research use only.
• It does not inhibit endogenous c-Myc protein activity or function in living cells.
• The peptide is insoluble in ethanol; attempts at dissolution in alcoholic solvents result in precipitation and loss of activity.
• Long-term storage of peptide solutions, even at –20°C, leads to aggregation and potency loss; always prepare fresh aliquots.
• High peptide concentrations may cause non-specific antibody interactions if not properly titrated.

Workflow Integration & Parameters

For optimal use, dissolve the c-Myc tag Peptide (SKU: A6003) at ≥60.17 mg/mL in DMSO or ≥15.7 mg/mL in water using ultrasonic treatment. Avoid ethanol. For immunoprecipitation, add the peptide post-wash at 1–10 μg/mL to displace bound c-Myc-tagged proteins. In Western blot blocking, use 5–20 μg/mL to confirm antibody specificity. Store lyophilized peptide desiccated at –20°C; avoid repeated freeze-thaw cycles. Use freshly prepared solutions to prevent degradation. The A6003 kit from APExBIO is validated for reproducibility and compatibility with common molecular biology buffers. This operational guidance updates and clarifies the practical perspectives offered in c-Myc tag Peptide: A Precision Tool for Dissecting Proto-oncogene Function.

Conclusion & Outlook

The c-Myc tag Peptide is a rigorously validated research reagent enabling precise control of protein–antibody interactions in immunoassays. Its unique sequence and solubility properties, coupled with evidence-based performance benchmarks, support its role as a gold standard in transcription factor and cancer biology research. Future developments may include engineered variants for multiplexed detection or enhanced solubility. Continued integration with advanced genomics and proteomics will expand its utility in dissecting oncogenic signaling networks. For detailed specifications and ordering, visit the c-Myc tag Peptide product page.